BASILIXIMAB

Benzonatate is a non-opioid antitussive that anesthetizes airway stretch receptors, reducing cough. Benefits include effective cough suppression. Side effects include dizziness, GI upset, and rare hypersensitivity.

SKU: 3383faffb888 Category: Tag:

Product Description


Mechanism of action

Basiliximab is a chimeric monoclonal antibody (IgG1κ) that selectively targets the interleukin‑2 receptor α‑chain (CD25) expressed on activated T‑lymphocytes. By binding CD25, basiliximab blocks IL‑2–mediated clonal expansion of T‑cells, preventing progression of the cellular immune response. As CD25 is upregulated only after T‑cell activation, basiliximab exhibits functional selectivity without widespread immunosuppression.

Benefits and advantages

Basiliximab is central in research on T‑cell activation, transplant immunology, cytokine signalling, graft rejection, and immunomodulator design. Its high receptor specificity allows precise modelling of IL‑2–driven lymphocyte proliferation and CD25‑targeted therapies. Useful in tolerance‑induction studies and comparison of biologic vs small‑molecule immunosuppressants.

Side effects and risks

Potential risks include hypersensitivity, infection susceptibility, lymphopenia, gastrointestinal disturbances and rare anaphylactoid reactions. As a monoclonal antibody, it must be handled under biological‑agent containment with protection from temperature fluctuations and contamination.

Datasheet


Molecular Weight

g/mol

CAS Number

179045-86-4

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

N/A chimeric monoclonal antibody

References

https://pubchem.ncbi.nlm.nih.gov/#query=179045-86-4;

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download